CompletedNot Applicable

Home-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer's Disease and Related Dementias (ADRD)

United States3 participantsStarted 2023-04-17

Plain-language summary

The purpose of this study is to assess acceptability, and safety of providing tDCS to ADRD patients with behavioral symptoms and to assess the efficacy of tDCS for ADRD-related symptoms, mainly behavioral symptoms.

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * have ADRD and clinically-meaningful behavioral symptoms * have a caregiver willing to participate in the study * can speak and read English * have stable doses of medications for at least one month Exclusion Criteria: * any unstable concurrent medical conditions * history of brain surgery * seizure * intracranial metal implantation * current alcohol/substance use disorder

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire

Timeframe: week 2

Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire

Timeframe: week 4

Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire

Timeframe: week 6

Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire

Timeframe: week 12

Safety as Assessed by the Side Effects Questionnaire

Timeframe: week 2

Safety as Assessed by the Side Effects Questionnaire

Timeframe: week 4

Safety as Assessed by the Side Effects Questionnaire

Timeframe: week 6

Trial details

NCT IDNCT05478681

SponsorThe University of Texas Health Science Center, Houston

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02-26

Results submitted2025-09-23

View on ClinicalTrials.gov More Alzheimer Disease trials

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire

Timeframe: week 2

Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire

Timeframe: week 4

Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire

Timeframe: week 6

Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire

Timeframe: week 12

Safety as Assessed by the Side Effects Questionnaire

Timeframe: week 2

Safety as Assessed by the Side Effects Questionnaire

Timeframe: week 4

Safety as Assessed by the Side Effects Questionnaire

Timeframe: week 6